Improved coronary risk assessment with electron beam computed tomography in an asymptomatic female with familial hypercholesterolemia

Mayo Clinic Proceedings

Volumn 74, Issue 10, 1999, Pages 1017-1020

  Möhlenkamp, Stefan ^a,b   Park, Jai Wun ^b   Grönemeyer, Dietrich ^c   Schwartz, Robert S ^d   Erbel, Raimund ^e  

^a Department of Physiology and Biophysics ^*  (United States)

^b MAYO CLINIC ROCHESTER   (United States)

^c University Heart Center Dresden   (Germany)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; LIPID;

ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; CORONARY RISK; DIAGNOSTIC ACCURACY; ELECTRON BEAM TOMOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; LIPID BLOOD LEVEL; PRACTICE GUIDELINE; RISK ASSESSMENT; SCORING SYSTEM;

EID: 0032841389     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)64000-7     Document Type: Article

References (23)

1. Agatston AS, Janowitz WR. Coronary calcification: detection by ultrafast computed tomography. In: Stanford W, Rumberger JA, eds. Ultrafast Computed Tomography in Cardiac Imaging: Principles and Practice. Mount Kisco, NY: Futura Publishing Co, Inc; 1992:77-95.
2. Janowitz WR, Agatston AS, Kaplan G, Viamonte M Jr. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. AmJCardiol. 1993;72:247-254.
3. Motulsky AG. Genetic aspects of familial hypercholesterolemia and its diagnosis. Arteriosclerosis. 1989;9(suppl I):13-I7.
4. Scientific Steering Committee, Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ. 1991:303:893-896.
5. Grundy SM, Balady GJ, Criqui MH, et al, American Heart Association. Primary prevention of coronary heart disease: guidance from Framingham: a statement for Healthcare professionals from the AHA Task Force on Risk Reduction. Circulation. 1998:97:1876-1887.
6. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998:97:1837-1847.
7. Mabuchi H, Koizumi J, Shimizu M, Takeda R. Development of coronary heart disease in familial hypercholesterolemia. Circulation. 1989:79:225-232.
8. Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet. 1969:2:1380-1382.
9. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995:1981-2030.
10. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 1993;269: 3015-3023.
11. Thiery J. Maximaltherapie der Hypercholesterinämie bei koronarer Herzkrankheit. Therapiewoche. 1988;38:3424-3437.
12. Seidel D. HELP Report 1994: 10 Years of Clinical Experience. Munich, Germany: MMV Medizin Verlag GmbH; 1994.
13. Greten H, Strauer BE, Kleophas W, Gries FA, Schuff-Werner P, Thiery J. LDL-Apherese: Ein therapeutisches Verfahren bei schwerer Hypercholesterinämie. Dt Arztebl. 1992;89(1/2):B37B38.
14. Gordon BR, Stein E, Jones P, Illingworth DR. Indications for lowdensity lipoprotein apheresis. Am J Cardiol. 1994;74:1109-1112.
15. Armstrong WF, Pellikka PA, Ryan T, Crouse L, Zoghbi WA, Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. J Am Sac Echocardiogr. 1998; 11:97-104.
16. Recommendations of the Task Force of the European Society of Cardiology: management of stable angina pectoris. Eur Heart J. 1997;18:394-413.
17. Gibbons RJ, Balady GJ, Beasley JW, et al, Committee on Exercise Testing. ACC/AHA guidelines for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 1997; 30:260-315.
18. Erbel R. The dawn of a new era-non-invasive coronary imaging. Herz. 1996:21:75-77.
19. Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999:74:243-252.
20. Rumberger JA, Sheedy PF, Breen JF, Schwartz RS. Electron beam computed tomographic coronary calcium score cutpoints and severity of associated angiographie lumen stenosis. J Am Coll Cardiol. 1997;29:1542-1548.
21. Budoff MJ, Georgiou D, Brody A, et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation. 1996;93:898-904.
22. Gidding SS, Bookstein LC, Chomka EV. Usefulness of electron beam tomography in adolescents and young adults with heterozygous familial hypercholesterolemia. Circulation. 1998:98:2580-2583.
23. Hoeg JM, Feuerstein IM, Tucker EE. Detection and quantitation of calcifié atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler Thromb. 1994;14:1066-1074.